What were the key revenue and earnings metrics for Q2 2025, and how do they compare to analyst expectations? | BYND (Aug 06, 2025) | Candlesense

What were the key revenue and earnings metrics for Q2 2025, and how do they compare to analyst expectations?

Answer

The press‑release excerpt you provided only announces that Beyond Meat, Inc. (NASDAQ: BYND) reported its second‑quarter 2025 financial results (for the quarter ended June 28 2025). It does not include the actual revenue figures, earnings (e.g., net income, adjusted EBITDA, or earnings per share), or any commentary on how those results compared to analysts’ forecasts.

Because the specific financial metrics and the analysts’ expectations are not disclosed in the excerpt, I’m unable to give you the key revenue and earnings numbers for Q2 2025, nor to explain whether the company beat, met, or missed consensus estimates.

What you can do next

  • Locate the full press release (often posted on Beyond Meat’s investor‑relations website or on GlobeNewswire). The complete document typically contains a table with:
    • Total net revenue (and sometimes a split between “plant‑based meat” and “other” segments)
    • Net loss or net income for the quarter
    • Adjusted EBITDA (or adjusted earnings) and adjusted EPS
    • Year‑over‑year percentage changes
  • Check analyst consensus estimates on a financial data platform (e.g., Bloomberg, FactSet, Thomson Reuters, or S&P Capital IQ). Those platforms list the average expected revenue and earnings per share that Wall Street analysts had forecast for the quarter.
  • Compare the two: Once you have both the actual results and the consensus estimates, you can calculate the variance (e.g., “Revenue of $ X billion, 5 % above the $ Y billion consensus estimate; adjusted EPS of $ Z, 10 % below the $ W consensus”).

If you can provide the full press‑release numbers (or a link to the complete announcement), I would be happy to analyze the results and detail how they stacked up against analyst expectations.

Other Questions About This News

Did the company address any regulatory or ESG developments that might influence its long‑term growth trajectory? What is the current inventory level versus demand, and are there any supply‑chain constraints that could affect future deliveries? What is the cash flow and balance sheet health after the quarter—specifically, free cash flow, debt levels, and capital‑expenditure plans? Did Beyond Meat provide any guidance or outlook for Q3 2025 and FY 2025, and what assumptions underpin that guidance? Has there been any update on product launches, new partnerships, or expansion into new retail channels that could drive future demand? Did the press release mention any buy‑back programs, dividend plans, or other shareholder‑return initiatives? How does the reported growth rate (or decline) in sales compare to previous quarters and to the broader plant‑based protein market? What are the margins (gross, operating, net) for Q2, and are there any notable cost‑structure changes impacting profitability? Are there any notable changes in geographic sales mix (e.g., North America vs. international markets) that could affect exposure to macro‑economic trends? What is the market's reaction so far (price movement, volume, options activity), and does it indicate any shift in sentiment or positioning? How does BYND's performance stack up against its main competitors (e.g., Impossible Foods, NestlĂ©, JBS Plant‑Based) in terms of volume, market share, and pricing power?